corporate_fare

Metsera Inc.

Address: 175 Greenwich Street, 3 World Trade Center

Sponsor Overview

assignment

Specializations

Obesity Treatment

Metsera Inc. focuses its clinical research on obesity and overweight, with trials centered on body-weight reduction and related metabolic health outcomes.

Weight management
Body weight reduction
Obesity pharmacotherapy

The sponsor also studies people with type 2 diabetes alongside excess body weight, reflecting interest in conditions where glycaemic control and adiposity are closely linked.

Metabolic Disease

Its research activity extends into metabolic disorders, particularly the clinical effects of therapies intended to improve cardiometabolic risk in adults with excess weight.

Metabolic health
Cardiometabolic risk
Glucose metabolism

Trials in this area include participants with obesity and type 2 diabetes, indicating a therapeutic interest in overlapping endocrine and metabolic conditions.

Endocrinology

Metsera Inc. is active in endocrinology through research addressing disorders of energy balance and glucose regulation.

Type 2 diabetes
Insulin resistance
Energy balance

The company’s studies align with therapeutic areas where hormonal regulation and metabolic function are central to disease management.

Trial Name	Country	Status
Efficacy and Safety of MET097 in Adults with Overweight or Obesity: A Phase 3, Randomized, Placebo-Controlled Trial	Bulgaria Czechia Germany Hungary Poland Romania Slovakia Spain	Not Recruiting
Phase 3 Randomized, Placebo‑Controlled Trial Assessing Efficacy and Safety of MET097, a Long‑Acting GLP‑1 Receptor Agonist, in Overweight/Obese Adults with Type 2 Diabetes	Bulgaria Czechia Germany Hungary Poland Romania Slovakia Spain	Not Recruiting